Role of protein kinase C in Ca2+ homeostasis disorders in cultured rat neurons during hyperstimulation of glutamate receptors

被引:0
作者
N. A. Persiyantseva
K. R. Birikh
E. A. Dvoretskova
V. G. Pinelis
B. I. Khodorov
机构
[1] Research Center of Child Health,Laboratory of Membranology
[2] Russian Academy of Medical Sciences,Institute of General Pathology and Pathophysiology
来源
Bulletin of Experimental Biology and Medicine | 2008年 / 145卷
关键词
protein kinase C; calcium; glutamate; neurons; phorbol ester;
D O I
暂无
中图分类号
学科分类号
摘要
The primary culture of rat cerebellar neurons was used to study protein kinase C activity, intracellular variations in calcium concentration ([Ca2+]i), changes in the mitochondrial potential, and neuronal death during hyperstimulation of glutamate receptors and after 24-h incubation with phorbol ester. Prolonged exposure of neurons to glutamate (100 µM, 45 min) was followed by the development of delayed calcium dysregulation. Protein kinase C activity depended on the time of cell incubation with glutamate. Protein kinase C activity increased in response to application of glutamate for 15 min. However, protein kinase C activity decreased after 45-min exposure to glutamate and development of delayed calcium dysregulation. Protein kinase C activity was nearly undetected after 24-h preincubation of neurons with phorbol ester. Under these conditions, delayed calcium dysregulation developed more slowly and was observed in a smaller number of neurons. Neuronal death decreased to 2±1%. Our results suggest that protein kinase C plays an important role in death of neurons, which exhibit delayed calcium dysregulation during glutamate treatment.
引用
收藏
页码:595 / 599
页数:4
相关论文
共 36 条
[1]  
Boldyrev A.(2004)undefined Biokhimiya 69 530-536
[2]  
Bulygina E.(2001)undefined Biol. Membrany 18 419-430
[3]  
Gerasimova O.(1999)undefined Trends Neurosci. 22 12-16
[4]  
Khodorov B. I.(1995)undefined Ann. N. Y. Acad. Sci. 747 162-171
[5]  
Storozhevykh T. P.(1997)undefined J. Neurochem. 68 1400-1412
[6]  
Surin A. M.(1990)undefined Proc. Natl. Acad. Sci. USA 87 1983-1987
[7]  
Chakravarthy B.(2004)undefined Prog. Biophys. Mol. Biol. 86 279-351
[8]  
Morley P.(2001)undefined Curr. Drugs Targets 2 299-312
[9]  
Whitfield J.(1989)undefined Mol. Pharmacol. 36 106-112
[10]  
Choi R.(1998)undefined FASEB J. 12 35-42